Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Rivaroxaban for stroke prevention in East Asian patients from the ROCKET AF trial.

Wong KS, Hu DY, Oomman A, Tan RS, Patel MR, Singer DE, Breithardt G, Mahaffey KW, Becker RC, Califf R, Fox KA, Berkowitz SD, Hacke W, Hankey GJ. Rivaroxaban for stroke prevention in East Asian patients from the ROCKET AF trial. Stroke. 2014 06; 45(6):1739-47.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.